Telomir Pharmaceuticals
TELO1.2306.96% ( +0.080 )
Telomir Pharmaceuticals (TELO)
Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream...
- Open
- 1.160
- High
- 1.230
- Low
- 1.150
- Prev. Close
- 1.150
- Volume
- 65.57K
- Turnover
- 77.97K
- Avg Price
- 1.189
- Bid/Ask Ratio
- --
- Amplitude
- 6.96%
- 52wk High
- 2.320
- Volume Ratio
- 0.31
- Turnover Ratio
- 0.14%
Telomir Pharmaceuticals Analyst Rating
View MoreForecast & Rating
Sep 9, 2025Price forecast
$15.501160.16%
Forecast & Rating-
0analysts
News
- TradingKey · Jul 23 at 09:19 AM
Tesla Inc Stock (TSLA) Moved Down by 12.68% on Jul 23: Facts Behind the Movement
- benzinga_article · Jul 21 at 12:05 PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
- Market Beat · Jul 21 at 01:20 AM
Telomir Pharmaceuticals (NASDAQ:TELO) Stock Price Down 17.2% - Here's Why
- PUBT · Jul 16 at 06:02 AM
Telo Genomics reports positive interim data for blood test predicting multiple myeloma relapse risk
- Electrek · Jul 14 at 11:10 AM
Pebble Flow electric RV towed by TELO’s MINI-sized electric truck
- PUBT · Jul 9 at 06:02 AM
Telo Genomics files US provisional patent for TeloView liquid biopsy MRD algorithm in multiple myeloma
